Engineering chimaeric recombinases for HIV-1 proviral DNA excision

Abioye, Jumai Adeola (2018) Engineering chimaeric recombinases for HIV-1 proviral DNA excision. PhD thesis, University of Glasgow.

Due to Embargo and/or Third Party Copyright restrictions, this thesis is not available in this service.
Printed Thesis Information: https://eleanor.lib.gla.ac.uk/record=b3310662

Abstract

‘Cutting out’ HIV-1 proviral DNA could potentially cure a person of the infection. Genome editing approaches have been proffered for eradicating the provirus in infected persons by activating all latent viral reservoirs for further antiretroviral therapy or for the excision of the proviral DNA from memory T- cells. Previous approaches to do this have used nuclease-based tools or reprogrammed tyrosine recombinases; the former presenting unpredictable therapeutic outcomes and the latter, lengthy design time for newer tool variants if viral mutability erodes their effectiveness. Unlike nuclease-based tools that only cut DNA and rely on host-mediated repair mechanisms, chimaeric recombinases (CRs) cut DNA and carry the inherent ability to re-ligate cut ends at the cleavage site. The modular domain architecture of small serine recombinases can be redesigned to mediate site-specific recombination on non-cognate sites, by replacing the C-terminal DNA binding domains (DBDs) of serine recombinases with programmable DBDs such as Zinc Finger (ZF) proteins, TAL effector proteins and CRISPR-dCas9. For HIV-1 proviral DNA excision, CR requirement for the interaction of two recombinase-bound sites, and the lack of necessity for host cell-encoded factors should maximize the fidelity and efficiency of provirus removal.

In this work, the engineering and characterization of CRs with the specificity to recognize and promote site-specific recombination at highly conserved regions within the HIV-1 proviral DNA is explored. This research provides a solid proof-of-concept for the use of CRs to target divergent novel target sequences, expanding their applicability for applied genome editing and wider biotechnological applications.

Item Type: Thesis (PhD)
Qualification Level: Doctoral
Keywords: Chimaeric recombinase, genome editing, recombination, synthetic biology, protein engineering, bioengineering, molecular biology.
Subjects: Q Science > QH Natural history > QH345 Biochemistry
Q Science > QH Natural history > QH426 Genetics
Q Science > QR Microbiology
Colleges/Schools: College of Science and Engineering > School of Engineering > Biomedical Engineering
Funder's Name: Engineering and Physical Sciences Research Council (EPSRC)
Supervisor's Name: Cooper, Professor Jonathan M. and Reboud, Dr. Julien and Stark, Professor Marshall W.
Date of Award: 2018
Embargo Date: 24 May 2020
Depositing User: J.A. Abioye
Unique ID: glathesis:2018-9143
Copyright: Copyright of this thesis is held by the author.
Date Deposited: 29 May 2018 08:53
Last Modified: 31 Jul 2019 09:23
URI: http://theses.gla.ac.uk/id/eprint/9143

Actions (login required)

View Item View Item